Fredrik Andersson
Direktor/Vorstandsmitglied bei ECTIN RESEARCH AB
Ursprung des Netzwerks ersten Grades von Fredrik Andersson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Fredrik Andersson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ZICCUM AB | Medical Specialties | Chairman Director of Finance/CFO | |
| LIPIDOR AB | Miscellaneous Commercial Services | Chairman Director of Finance/CFO | |
| Emollivet AB | Chairman Director of Finance/CFO | ||
| INHALATION SCIENCES SWEDEN AB | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
| SENSIDOSE AB | Electronic Equipment/Instruments | Comptroller/Controller/Auditor Director of Finance/CFO | |
| ONCOZENGE AB | Pharmaceuticals: Major | Director of Finance/CFO | |
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Biotechnology | Chief Executive Officer | |
| University of Gothenburg | College/University | Doctorate Degree | |
Entreprenörskapital i Sverige AB
 Entreprenörskapital i Sverige AB Investment Banks/BrokersFinance Entreprenörskapital i Sverige AB provides activities of securities and commodity brokers. It attracts companies to support companies in a start-up phase. It is the products of the collective wealth of risk capital experience. It desires to explore new approaches to investing in unlisted companies. It delivers benefits to investors, entrepreneurs, customers, and society. The company was founded by Raymond Peter Wendel on January 12, 2011 and is headquartered in Gothenburg, Sweden. | Investment Banks/Brokers | Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member | |
| Handelshögskolan i Göteborg | College/University | Graduate Degree | |
Inorbit Therapeutics AB
 Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Lecra AB | Director/Board Member | ||
| Dizlin Pharmaceuticals AB | Comptroller/Controller/Auditor | ||
| O Mgmt AB | Corporate Officer/Principal | ||
| LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Director of Finance/CFO | |
Ancoria Insurance Ltd.
 Ancoria Insurance Ltd. Multi-Line InsuranceFinance Ancoria Insurance Ltd. provides insurance services. It offers life insurance policies and occupational pension schemes. The company was founded by Sievert Larsson in 1987 and is headquartered in Nicosia, Cyprus. | Multi-Line Insurance | Director/Board Member | |
| SP HMSO Göteborg AB | Director/Board Member | ||
| University of Stockholm | College/University | Graduate Degree | |
Theradex (Europe) Ltd.
 Theradex (Europe) Ltd. BiotechnologyHealth Technology Founded in 1992, Theradex (Europe) Ltd. is a subsidiary of Theradex Systems, Inc. that engages in research and experimental development on biotechnology. The company is based in Crawley, UK. | Biotechnology | Corporate Officer/Principal | |
Link Medical Research AB
 Link Medical Research AB Miscellaneous Commercial ServicesCommercial Services Part of Link Medical Research AS, Link Medical Research AB is a company that provides product development services for the pharmaceutical and medical device industries. The company is based in Solna, Sweden. The Swedish company was founded in 1995 by Ola Gudmundsen. Ola Gudmundsen has been the CEO since 1995. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Royal College of Surgeons | College/University | Undergraduate Degree | |
Sinfonia Biotherapeutics AB
 Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a clinical stage company based in Huddinge, Sweden. The Swedish company develops biologics for the treatment of neuropathic pain. | Biotechnology | Director of Finance/CFO | |
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Pharmaceuticals: Major | Director of Finance/CFO | |
| BIOEXTRAX AB | Biotechnology | Director of Finance/CFO | |
| GABATHER AB | Pharmaceuticals: Major | Director of Finance/CFO | |
| HOODIN AB | Packaged Software | Director/Board Member | |
| Medlys HB | Corporate Officer/Principal | ||
| Sahlgrenska University | College/University | Corporate Officer/Principal | |
Ivarsson Medical Research AB
 Ivarsson Medical Research AB Investment Banks/BrokersFinance Ivarsson Medical Research AB is a Swedish company that engages in the management and trading of securities. The CEO of the private company is Marie-Lois Ivarsson. | Investment Banks/Brokers | Chief Executive Officer | |
| Uronauten AB | Director/Board Member | ||
| Lennart ekerholms stiftelse | Investment Trusts/Mutual Funds | Director/Board Member | |
RGNT Electric AB
 RGNT Electric AB Motor VehiclesConsumer Durables RGNT Electric AB is a Swedish company that specializes in electric motorcycles. The company is based in Kungsbacka, Sweden. The company's range of motorbikes is both timeless and forward-thinking. RGNT Electric was founded in 2019 by Jonathan Åström. Göran Karlsson has been the CEO of the company since January 12, 2023. | Motor Vehicles | Director/Board Member | |
| Improve Tec Hönö AB | Chairman | ||
| Lecra Eco Sustain AB | Director/Board Member | ||
Trece AB
 Trece AB Specialty StoresRetail Trade Part of Garpco AB, Trece AB is a Swedish company that specializes in the design and manufacturing of lockable wardrobes for personal storage of outerwear, bags, shoes, and more. The company is based in Norrköping, Sweden. The company's CombiLine wardrobes come with a hat shelf and clothes rail as standard, offering convenient and space-efficient storage solutions. With a focus on flexibility, functionality, and design, Trece creates furniture that seamlessly blends into work environments. | Specialty Stores | Director of Finance/CFO | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Corporate Officer/Principal | |
| Chalmers University of Technology | College/University | Graduate Degree | |
Ultimovacs AB
 Ultimovacs AB Pharmaceuticals: MajorHealth Technology Part of Ultimovacs ASA, Ultimovacs AB engages in pharmaceutical development. The CEO of the Swedish company is Carlos de Sousa. Ultimovacs was acquired by Ultimovacs ASA from Immuneed AB on August 29, 2018 for $6.05 million. | Pharmaceuticals: Major | Chief Executive Officer | |
| ULTIMOVACS ASA | Pharmaceuticals: Major | Chief Executive Officer | |
| MENDUS AB | Biotechnology | Chief Executive Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Schweden | 42 |
| Dänemark | 3 |
| Norwegen | 3 |
| Frankreich | 2 |
| Zypern | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 4 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 27 |
| Corporate Officer/Principal | 17 |
| Director of Finance/CFO | 17 |
| Chief Executive Officer | 14 |
| Chairman | 11 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Fredrik Andersson
- Unternehmensverbindungen
